May 7, 2025
Four years after its inception, NewLimit's quest to extend healthy human lifespan through cellular reprogramming has attracted substantial financial backing. The biotech startup, co-founded by Coinbase CEO Brian Armstrong, has secured $130 million in Series B funding led by Kleiner Perkins, building on their $40 million Series A from two […]